- Home
- PH vs BMY Comparison
PH vs BMY Comparison
Compare PH & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PH | BMY |
|---|---|---|
| Founded | 1917 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.2B | 110.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PH | BMY |
|---|---|---|
| Price | $940.65 | $54.88 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 14 |
| Target Price | ★ $933.86 | $57.64 |
| AVG Volume (30 Days) | 497.3K | ★ 12.2M |
| Earning Date | 01-29-2026 | 02-05-2026 |
| Dividend Yield | 0.77% | ★ 4.59% |
| EPS Growth | ★ 26.57 | N/A |
| EPS | ★ 28.09 | 2.97 |
| Revenue | $20,030,000,000.00 | ★ $48,034,000,000.00 |
| Revenue This Year | $9.51 | $0.28 |
| Revenue Next Year | $7.33 | N/A |
| P/E Ratio | $33.44 | ★ $18.50 |
| Revenue Growth | 0.22 | ★ 1.26 |
| 52 Week Low | $488.45 | $42.52 |
| 52 Week High | $954.30 | $63.33 |
Technical Indicators
Market Signals| Indicator | PH | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 63.20 | 53.85 |
| Support Level | $923.00 | $53.55 |
| Resistance Level | $939.97 | $57.04 |
| Average True Range (ATR) | 18.16 | 1.22 |
| MACD | 0.52 | -0.32 |
| Stochastic Oscillator | 80.82 | 55.32 |
Price Performance
Historical ComparisonAbout PH Parker-Hannifin Corporation
Parker Hannifin started out in 1917 as Parker Appliance, selling pneumatic brakes. Through the acquisition of branded components, the firm has expanded into aerospace engines, agricultural and construction machinery, freight and passenger vehicles, and industrial automation equipment. Within these larger systems, Parker sells a wide array of small, critical pieces such as hydraulic, electromechanical, climate control, and filtration components. Many of its products are designed to work together, resulting in a high rate of cross-selling.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.